Advancing Quality-of-life Research by Deepening Our Understanding of Response Shift: a Unifying Theory of Appraisal
Overview
Rehabilitation Medicine
Authors
Affiliations
Studies of response-shift phenomena in quality-of-life (QOL) research have grown steadily in the more than two decades of research. As a field, we have been calling a lot of different approaches "response shift" over the years, but the only approach that fully embodies the foundational (Sprangers and Schwartz, Soc Sci Med 48(11):1507-1515, 1999) theoretical model is appraisal. According to the definition proposed in this model, response shift is about individual cognitive change. This paper presents the argument that all response-shift research models need to be grounded in an understanding of cognitive appraisal. We present a reasoned argument for why appraisal is fundamental to QOL response-shift research. We describe current measurement and analytic methods for working with appraisal, and how these methods can be integrated into the current response-shift statistical 'tool box.' We propose future research directions on theory, methods, and cross-calibration of group- and individual-level methods. There are currently three tools available in multiple languages for assessing QOL appraisal processes. They have been tested and used to assess response shift in empirical studies of ~ 7000 people with chronic illness. The study findings illustrate how appraisal theory and methods can facilitate methodological investigations of and to enhance other response-shift detection methods. Future research directions are proposed to enrich QOL theory, response-shift methods, and interpretation of QOL change over time. Appraisal theory and methods are the closest approximation to a response-shift 'gold standard.' They provide the foundation for understanding response shift and point to a unified theory of QOL.
Loibnegger-Traussnig K, Schwerdtfeger A, Flaggl F Int J Behav Med. 2024; .
PMID: 39656350 DOI: 10.1007/s12529-024-10340-z.
Giannelos N, Francq B, Curran D Clin Drug Investig. 2024; 44(5):293-301.
PMID: 38662318 PMC: 11088541. DOI: 10.1007/s40261-024-01355-1.
Schwartz C, Borowiec K, Rapkin B, Finkelstein J J Pers Med. 2024; 14(3).
PMID: 38541071 PMC: 10971056. DOI: 10.3390/jpm14030329.
Bauquier C, Ginguene S, Leroy T, Doumergue M, Lebrun N, Della Vecchia C Qual Life Res. 2024; 33(5):1423-1431.
PMID: 38502415 DOI: 10.1007/s11136-024-03626-y.
Schwartz C, Borowiec K, Li Y, Rapkin B Qual Life Res. 2024; 33(4):927-939.
PMID: 38183562 DOI: 10.1007/s11136-023-03573-0.